Peeling of the ILM from the retinal surface with finesse forceps; the PRECISE study

The Newcastle Upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 65 人开始时间: 2019年9月6日最近更新: 2023年7月25日

适应症

试验速览

2023 Results article in https://doi.org/10.1007/s00417-022-05932-y (added 10/07/2023)

•1. Primary idiopathic macular hole of any size and less than 12-month duration
•2. Other previous treatments (gas, OCP) allowed
•3. Full comprehension of study requirements at time of consent (at discretion of clinician)
•4. Aged 50 years or older

•1. ILM peeling not planned
•2. MH secondary to other causes including trauma, previous retinal detachment
•3. Previous vitrectomy surgery
•4. Previous significant macular disease affecting visual acuity (mild early or intermediate AMD allowed)
•5. Advanced glaucoma
•6. Known vision affecting optic nerve disease
•7. Diabetic retinopathy of more than R1 including previously treated PDR
•8. Significant intraocular inflammation
•9. Myopia > -6 dioptres or axial length > 26mm
•10. Amblyopia of less than ~6/18
•11. Conditions affecting ability to perform visual fields or imaging
•12. Participation in any other clinical/interventional trial that may impact study findings

发起方